While further studies in human populations are required to confirm maternal and neonatal protection from pre-pregnancy weight loss intervention, our findings provide promise of metabolic and renal benefit of pre-conception GLP1-RA intervention for reproductive-age females with obesity. Here, GLP1R is linked to obesity disorder.